Thanks for highlighting that aspect, Krushingit. Cabotamig wasn't something I wanted to go delving too deep into, but now that you have raised the scenario, it looks as though I will have to rush off and buy some Arbele shares! Only joking!!!
There appear to be already a number of Bispecifics on the commercial market for the purpose of providing "maintenance" treatment for cancer sufferers.
This slide puts our CDH17 and CLTX targeted assets in perspective:-
Maybe Dr Durie could fill in for me!!!
Chimeric: Media Thread, page-690
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.002(20.0%) |
Mkt cap ! $11.70M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.3¢ | 1.0¢ | $153.9K | 13.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 128195 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 1224999 | 4 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |